Merdury Biopharmaceutical Corporation (TPEX:6932)
5.51
+0.02 (0.36%)
Aug 19, 2026, 12:55 PM CST
-36.52% (1Y)
| Market Cap | 2.29B -38.1% |
| Revenue (ttm) | n/a |
| Net Income | -51.62M |
| EPS | -0.12 |
| Shares Out | 422.03M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 443,234 |
| Open | 5.25 |
| Previous Close | 5.49 |
| Day's Range | 5.25 - 5.51 |
| 52-Week Range | 4.71 - 12.20 |
| Beta | -1.12 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 20, 2026 |